Sofosbuvir, Glecaprevir, Pibrentasvir, and Ribavirin as a Rescue Therapy in Difficult-to-Treat HCV Patients

Magdalena Meszaros; Régine Truchi; Denis Ouzan; Albert Tran; Marc Bourlière; Georges Philippe Pageaux

Journal Article

Sofosbuvir, Glecaprevir, Pibrentasvir, and Ribavirin as a Rescue Therapy in Difficult-to-Treat HCV Patients

Hepatology (2021) 74(4) 2304-2306

DOI: 10.1002/hep.31909

7Citations

9Readers

Get full text

Cite

CITATION STYLE

APA

Meszaros, M., Truchi, R., Ouzan, D., Tran, A., Bourlière, M., & Pageaux, G. P. (2021). Sofosbuvir, Glecaprevir, Pibrentasvir, and Ribavirin as a Rescue Therapy in Difficult-to-Treat HCV Patients. Hepatology, 74(4), 2304–2306. https://doi.org/10.1002/hep.31909

Sofosbuvir, Glecaprevir, Pibrentasvir, and Ribavirin as a Rescue Therapy in Difficult-to-Treat HCV Patients

Cite

Register to see more suggestions